🔊 We are thrilled to announce our contribution to the Slovenian Veterinary Research journal with our editorial, ‘Rediscovering Phage Therapy: A Promising Approach for Combating Antimicrobial Resistance.’ ⚗ 🔊 In this piece, we highlight the critical issue of antimicrobial resistance and explore how phage therapy could be a powerful solution. We also examine its applications in veterinary medicine and discuss the current regulatory landscape for phage product development.🐶🐱🐴 🔊 For a deeper dive into the potential of phage therapy in small animal veterinary medicine, check out also the article, ‘Skin Dysbiosis in Atopic Dogs: Is Phage Therapy an Alternative to Antibiotics?’ here: https://lnkd.in/ewxBWMbB. #COBIK #phagetherapy #veterinarymedicine #antimicrobialresistance #research
Antimicrobial resistance (AMR) poses a serious threat to human, animal, and environmental health. Bacteriophage therapy, using viruses to target bacteria, shows promise in combating AMR. Regulatory challenges exist, but new guidelines are paving the way for its use in medicine. https://lnkd.in/drS33cej #AMR #PhageTherapy
Christine Khan
8mo
Really interesting read. Thank you for sharing. Developing alternative solutions is so critical in the fight against antimicrobial resistance. Astrea Bioseparations supports the bacteriophage industry with our product Etoxiclear which is used to remove endotoxins, a by-product of the manufacturing process. If you need more details, please reach out to Henry Pratt. We have 1ml columns of etoxiclear for screening so you can see the results for yourself!
Driving Business Growth through Strategic Partnerships
7moUrban Bezeljak 🎉 Congratulations on your impressive editorial on phage therapy as a promising solution for antimicrobial resistance. Your team's dedication to advancing veterinary medicine and exploring innovative treatments is truly inspiring. Kudos to everyone involved!